由CAR-T细胞表达的互白素-7改善了CAR-T细胞的存活率和在胆瘤中的疗效

Huantong Wu1,2, Zhuofan Xu1,2, Maoyang Qi1,2

  • 1Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

概括

这项研究确定了B7-H3作为标,IL-7作为瘤免疫疗法的强化剂. 将B7-H3向的化学抗原受体T (CAR-T) 细胞与IL-7结合起来,显示出增强的抗瘤活性.